
Lecanemab was found to slow cognitive decline caused by the brain-wasting disease (Stock image)
(Picture: PA Archive)A dementia charity has hailed a “historic moment” in Alzheimer’s research after a new drug was found to reduce cognitive decline in patients with early-stage disease.
Lecanemab was found to slow cognitive decline caused by the brain-wasting disease by 27 per cent over an 18-month period compared with a placebo.